Predictors of colorectal cancer following a negative in the medicare population

Amanpal Singh, Yong Fang Kuo, Taylor S. Riall, G. S. Raju, James Goodwin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: The incidence of colorectal cancer following a normal colonoscopy in the Medicare population is not known. Methods: A 5% national sample of Medicare enrollees from 1996 to 2005 was used to identify patients undergoing complete colonoscopy. A colonoscopy not associated with any procedure (e.g., biopsy, polypectomy or fulguration) was defined as a negative colonoscopy. Patients with history of inflammatory bowel disease, colorectal cancer or death within 12 months of colonoscopy were excluded. A multivariable model was constructed to evaluate the factors associated with a new diagnosis of colorectal cancer in the period from 12 to 120 months following the negative colonoscopy. Results: Among 200,857 patients (mean age 74 years, 61% female, 92% White) with a negative colonoscopy, the incidence of colorectal cancer was 1.8 per 1,000 person-years. The incidence rate for matched follow-up periods decreased from 2.0/1,000 person-years for patients undergoing colonoscopy during 1996-2000 to 1.2/1,000 person years during 2001-2005. Multivariate analysis revealed a significant regional variation in the incidence of colorectal cancer following a negative colonoscopy. The incidence was higher in patients >85 years, males and patients who underwent a negative colonoscopy by a non-gastroenterologist or endoscopist in the lowest volume quartile. On stratified analyses, endoscopist volume was a significant predictor for non-gastroenterologists only. Conclusions: The specialty and experience of the endoscopist are significant predictors of the incidence rate of colorectal cancer in Medicare patients with a negative colonoscopy.

Original languageEnglish (US)
Pages (from-to)3122-3128
Number of pages7
JournalDigestive Diseases and Sciences
Volume56
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Colonoscopy
Medicare
Colorectal Neoplasms
Population
Incidence
Inflammatory Bowel Diseases
Multivariate Analysis
Biopsy

Keywords

  • Colon cancer
  • Colonoscopy
  • Diagnostic errors
  • Missed diagnosis
  • Regional variation

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Predictors of colorectal cancer following a negative in the medicare population. / Singh, Amanpal; Kuo, Yong Fang; Riall, Taylor S.; Raju, G. S.; Goodwin, James.

In: Digestive Diseases and Sciences, Vol. 56, No. 11, 11.2011, p. 3122-3128.

Research output: Contribution to journalArticle

Singh, Amanpal ; Kuo, Yong Fang ; Riall, Taylor S. ; Raju, G. S. ; Goodwin, James. / Predictors of colorectal cancer following a negative in the medicare population. In: Digestive Diseases and Sciences. 2011 ; Vol. 56, No. 11. pp. 3122-3128.
@article{275c4260fbc64e8f8170f3c6e086a4a5,
title = "Predictors of colorectal cancer following a negative in the medicare population",
abstract = "Background: The incidence of colorectal cancer following a normal colonoscopy in the Medicare population is not known. Methods: A 5{\%} national sample of Medicare enrollees from 1996 to 2005 was used to identify patients undergoing complete colonoscopy. A colonoscopy not associated with any procedure (e.g., biopsy, polypectomy or fulguration) was defined as a negative colonoscopy. Patients with history of inflammatory bowel disease, colorectal cancer or death within 12 months of colonoscopy were excluded. A multivariable model was constructed to evaluate the factors associated with a new diagnosis of colorectal cancer in the period from 12 to 120 months following the negative colonoscopy. Results: Among 200,857 patients (mean age 74 years, 61{\%} female, 92{\%} White) with a negative colonoscopy, the incidence of colorectal cancer was 1.8 per 1,000 person-years. The incidence rate for matched follow-up periods decreased from 2.0/1,000 person-years for patients undergoing colonoscopy during 1996-2000 to 1.2/1,000 person years during 2001-2005. Multivariate analysis revealed a significant regional variation in the incidence of colorectal cancer following a negative colonoscopy. The incidence was higher in patients >85 years, males and patients who underwent a negative colonoscopy by a non-gastroenterologist or endoscopist in the lowest volume quartile. On stratified analyses, endoscopist volume was a significant predictor for non-gastroenterologists only. Conclusions: The specialty and experience of the endoscopist are significant predictors of the incidence rate of colorectal cancer in Medicare patients with a negative colonoscopy.",
keywords = "Colon cancer, Colonoscopy, Diagnostic errors, Missed diagnosis, Regional variation",
author = "Amanpal Singh and Kuo, {Yong Fang} and Riall, {Taylor S.} and Raju, {G. S.} and James Goodwin",
year = "2011",
month = "11",
doi = "10.1007/s10620-011-1788-6",
language = "English (US)",
volume = "56",
pages = "3122--3128",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Predictors of colorectal cancer following a negative in the medicare population

AU - Singh, Amanpal

AU - Kuo, Yong Fang

AU - Riall, Taylor S.

AU - Raju, G. S.

AU - Goodwin, James

PY - 2011/11

Y1 - 2011/11

N2 - Background: The incidence of colorectal cancer following a normal colonoscopy in the Medicare population is not known. Methods: A 5% national sample of Medicare enrollees from 1996 to 2005 was used to identify patients undergoing complete colonoscopy. A colonoscopy not associated with any procedure (e.g., biopsy, polypectomy or fulguration) was defined as a negative colonoscopy. Patients with history of inflammatory bowel disease, colorectal cancer or death within 12 months of colonoscopy were excluded. A multivariable model was constructed to evaluate the factors associated with a new diagnosis of colorectal cancer in the period from 12 to 120 months following the negative colonoscopy. Results: Among 200,857 patients (mean age 74 years, 61% female, 92% White) with a negative colonoscopy, the incidence of colorectal cancer was 1.8 per 1,000 person-years. The incidence rate for matched follow-up periods decreased from 2.0/1,000 person-years for patients undergoing colonoscopy during 1996-2000 to 1.2/1,000 person years during 2001-2005. Multivariate analysis revealed a significant regional variation in the incidence of colorectal cancer following a negative colonoscopy. The incidence was higher in patients >85 years, males and patients who underwent a negative colonoscopy by a non-gastroenterologist or endoscopist in the lowest volume quartile. On stratified analyses, endoscopist volume was a significant predictor for non-gastroenterologists only. Conclusions: The specialty and experience of the endoscopist are significant predictors of the incidence rate of colorectal cancer in Medicare patients with a negative colonoscopy.

AB - Background: The incidence of colorectal cancer following a normal colonoscopy in the Medicare population is not known. Methods: A 5% national sample of Medicare enrollees from 1996 to 2005 was used to identify patients undergoing complete colonoscopy. A colonoscopy not associated with any procedure (e.g., biopsy, polypectomy or fulguration) was defined as a negative colonoscopy. Patients with history of inflammatory bowel disease, colorectal cancer or death within 12 months of colonoscopy were excluded. A multivariable model was constructed to evaluate the factors associated with a new diagnosis of colorectal cancer in the period from 12 to 120 months following the negative colonoscopy. Results: Among 200,857 patients (mean age 74 years, 61% female, 92% White) with a negative colonoscopy, the incidence of colorectal cancer was 1.8 per 1,000 person-years. The incidence rate for matched follow-up periods decreased from 2.0/1,000 person-years for patients undergoing colonoscopy during 1996-2000 to 1.2/1,000 person years during 2001-2005. Multivariate analysis revealed a significant regional variation in the incidence of colorectal cancer following a negative colonoscopy. The incidence was higher in patients >85 years, males and patients who underwent a negative colonoscopy by a non-gastroenterologist or endoscopist in the lowest volume quartile. On stratified analyses, endoscopist volume was a significant predictor for non-gastroenterologists only. Conclusions: The specialty and experience of the endoscopist are significant predictors of the incidence rate of colorectal cancer in Medicare patients with a negative colonoscopy.

KW - Colon cancer

KW - Colonoscopy

KW - Diagnostic errors

KW - Missed diagnosis

KW - Regional variation

UR - http://www.scopus.com/inward/record.url?scp=82555174388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82555174388&partnerID=8YFLogxK

U2 - 10.1007/s10620-011-1788-6

DO - 10.1007/s10620-011-1788-6

M3 - Article

C2 - 21681506

AN - SCOPUS:82555174388

VL - 56

SP - 3122

EP - 3128

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 11

ER -